Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight(Translational Therapeutics (United States)), Erik Ingelsson(Wave Life Sciences (United States)), Heribert Schunkert(German Centre for Cardiovascular Research), Bruna Gigante(Danderyds sjukhus), Christopher Newton‐Cheh(Massachusetts General Hospital), James P. Pirruccello(University of California, San Francisco), John A. Spertus(Saint Luke's Health System), Vincent Mooser(McGill University), Guðmar Þorleifsson(deCODE Genetics (Iceland)), Domenico Girelli(University of Verona), Ida Surakka(University of Helsinki), Danish Saleheen(Columbia University Irving Medical Center), Guðmundur Þorgeirsson(Sahlgrenska University Hospital), John F. Thompson(The University of Sydney), George Hindy(Regeneron (United States)), Gina M. Peloso(Boston University), Nicola Martinelli(University of Verona), Pascal McKeown(Queen's University Belfast), Kiran Musunuru(University of Pennsylvania), Ulf dé Fairé(Karolinska Institutet), Joseph Devaney(MedStar Washington Hospital Center), Unnur Þorsteinsdóttir(deCODE Genetics (Iceland)), Markus Perola(Broad Institute), Aki S. Havulinna(Finnish Institute for Health and Welfare), Samuli Ripatti(Broad Institute), Markku S. Nieminen(Cornell University), Juha Sinisalo(University of Helsinki), Thomas M. Morgan(Vanderbilt University Medical Center), Monika Stoll(University of Münster), Marju Orho‐Melander(Lund University), James C. Engert(MedStar Washington Hospital Center), Mary-Susan Burnett(MedStar Washington Hospital Center), Ruth Frikke‐Schmidt(University of Copenhagen), Arne Schillert(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Majken K. Jensen(University of Copenhagen), Jemma C. Hopewell(Unknown), Eric L. Ding(Brown University), Li Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Nilesh J. Samani(University of Leicester), Mingyao Li(California University of Pennsylvania), Robert Clarke(Medical Research Council), Klaus Berger(University Hospital Münster), Stephen E. Epstein(Forma Therapeutics (United States)), Maja Barbalić(Center for Human Genetics), Marja‐Liisa Lokki(University of Helsinki), Hilma Holm(deCODE Genetics (Iceland)), Christopher Patterson(University of Wollongong), Alexandre F.R. Stewart(University of Ottawa), Sonia S. Anand(Reykjavík University), Toby Johnson(North Devon District Hospital)
Cited by 119
Related Papers
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k